![Jennifer Buell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Buell
Directeur Général chez
MINK THERAPEUTICS, INC.
Fortune : 775 975 $ au 31/05/2026
Profil
Dr. Jennifer S.
Buell is a President, Chief Executive Officer & Director at MiNK Therapeutics, Inc., an Independent Director at Protagenic Therapeutics, Inc., a Chief Executive Officer at AgenTus Therapeutics Ltd. and a Chief Executive Officer at AgenTus Therapeutics SA. She is on the Board of Directors at Agenus, Inc., MiNK Therapeutics, Inc. and Protagenic Therapeutics, Inc. She received her graduate degree from Tufts University and a doctorate degree from Tufts University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MINK THERAPEUTICS, INC. 1,16 % | 23/04/2026 | 57 942 ( 1,16 % ) | 706 892 $ | 31/05/2026 |
AGENUS INC. 0,05 % | 24/04/2026 | 19 738 ( 0,05 % ) | 69 083 $ | 31/05/2026 |
| 30/11/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Jennifer Buell
| Sociétés | Poste | Début |
|---|---|---|
| PROTAGENIC THERAPEUTICS, INC. | Directeur/Membre du Conseil | 18/07/2020 |
| MINK THERAPEUTICS, INC. | Directeur Général | 01/02/2021 |
| AGENUS INC. | Directeur/Membre du Conseil | 11/06/2024 |
AgenTus Therapeutics SA | Directeur Général | - |
AgenTus Therapeutics Ltd. | Directeur Général | - |
Anciens postes connus de Jennifer Buell
| Sociétés | Poste | Fin |
|---|---|---|
| AGENUS INC. | President | 31/12/2021 |
Formation de Jennifer Buell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagenic Therapeutics, Inc.
 Protagenic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that engages in discovery and development of therapeutics to treat stress-related neuropsychiatric & mood disorders | Health Technology |
MiNK Therapeutics, Inc.
 MiNK Therapeutics, Inc. BiotechnologyHealth Technology Provides bio pharmaceutical services | Health Technology |
AgenTus Therapeutics Ltd. | |
AgenTus Therapeutics SA |
